PRODUCT DETAIL

Levocetirizin Dr.Max 5 mg filmom obalené tablety

Code

1265A

MA number

24/0243/12-S

Product Form:

tbl flm 50x5 mg (blis.Al/OPA/Al/PVC)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Dr. Max Pharma s.r.o., Czechia

Therapeutic Class:

24 - ANTIHISTAMINICA, HISTAMIN

ATC:

R	RESPIRATORY SYSTEM
R06	ANTIHISTAMINES FOR SYSTEMIC USE
R06A	ANTIHISTAMINES FOR SYSTEMIC USE
R06AE	Piperazine derivatives
R06AE09	Levocetirizine

Shelf life:

Container:

blister Al/OPA/Al/PVC

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	23.05.2012
Pediatric posology:	Yes
SPC:	SPC_Levocetirizin Dr.Max 5 mg tbl flm_01.2024.pdf
PIL:	PIL_Levocetirizin Dr.Max 5 mg_OTC_11/2024.pdf
PIL:	PIL_Levocetirizin Dr.Max 5 mg_Rx_11/2024.pdf
Safety feature	Yes
Data update:	21.09.2018